Singapore markets closed

Straits Times Index
3,296.89
+4.20(+0.13%)
S&P 500
5,022.51
+4.12(+0.08%)
Dow
37,954.33
+51.04(+0.13%)
Nasdaq
15,652.99
+47.50(+0.30%)
Bitcoin USD
58,604.73
+1,360.00(+2.38%)
CMC Crypto 200
1,259.93
-10.81(-0.85%)

ABT Jan 2025 125.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

2.3500

+0.2000

(+9.30%)

As of 09:33AM EDT. Market open.

Zacks
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Zacks
PBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR Newswire
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.